Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Kakiuchi, Yasutaka ^a   Nagai, Jun ^b   Gotoh, Mari ^a   Hotta, Harumi ^c   Murofushi, Hiromu ^a   Ogawa, Tomoyo ^b   Ueda, Hiroshi ^b   Murakami Murofushi, Kimiko ^a  

^a OCHANOMIZU UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 CARBACYCLIC PHOSPHATIDIC ACID; CYCLIC PHOSPHATIDIC ACID; GABAPENTIN; GLYCEROPHOSPHOLIPID; MORPHINE; UNCLASSIFIED DRUG; 2 CARBA CYCLIC PHOSPHATIDIC ACID; 2-CARBA-CYCLIC PHOSPHATIDIC ACID; FORMALDEHYDE; LYSOPHOSPHOLIPID; PHOSPHATIDIC ACID; PHOSPHINE OXIDE DERIVATIVE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; FEMALE; HYPERALGESIA; LICKING; MALE; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SINGLE DRUG DOSE; SYMPATHETIC REFLEX; WITHDRAWAL REFLEX; ACUTE DISEASE; ADRENERGIC SYSTEM; ANESTHESIA; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CHEMISTRY; CHRONIC DISEASE; DISEASE MODEL; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NOCICEPTIVE RECEPTOR; PATHOLOGY; PATHOPHYSIOLOGY; REFLEX; TEMPERATURE; WISTAR RAT;

ACUTE DISEASE; ANESTHESIA; ANIMALS; BEHAVIOR, ANIMAL; CHRONIC DISEASE; CYCLIC P-OXIDES; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; FORMALDEHYDE; HYPERALGESIA; INJECTIONS, INTRAVENOUS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; NOCICEPTORS; PAIN; PHOSPHATIDIC ACIDS; RATS; RATS, WISTAR; REFLEX; SYMPATHETIC NERVOUS SYSTEM; TEMPERATURE;

EID: 79955876352     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-33     Document Type: Article

References (34)

1. Murakami-Murofushi K, Shioda M, Kaji K, Yoshida S, Murofushi H. Inhibition of eukaryotic DNA polymerase alpha with a novel lysophosphatidic acid (PHYLPA) isolated from myxoamoebae of Physarum polycephalum. J Biol Chem 1992, 267(30):21512-21517.
2. Kobayashi S, Tokunoh R, Shibasaki M, Shinagawa R, Murakami-Murofushi K. Synthesis of 1-O-acyiglycerol 2,3-cyclic phosphate: determination of the absolute structure of PHYLPA, a specific inhibitor of DNA polymerase α. Tetrahedron Lenten 1993, 34(25):4047-4050.
3. Murakami-Murofushi K, Uchiyama A, Fujiwara Y, Kobayashi T, Kobayashi S, Mukai M, Murofushi H, Tigyi G. Biological functions of a novel lipid mediator, cyclic phosphatidic acid. Biochim Biophys Acta 2002, 1582(1-3):1-7.
4. Fujiwara Y. Cyclic phosphatidic acid - a unique bioactive phospholipid. Biochim Biophys Acta 2008, 1781(9):519-524. 2572151, 18554524.
5. Fischer DJ, Liliom K, Guo Z, Nusser N, Virag T, Murakami-Murofushi K, Kobayashi S, Erickson JR, Sun G, Miller DD, Tigyi G. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. Mol Pharmacol 1998, 54(6):979-988.
6. Mukai M, Imamura F, Ayaki M, Shinkai K, Iwasaki T, Murakami-Murofushi K, Murofushi H, Kobayashi S, Yamamoto T, Nakamura H, Akedo H. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA). Int J Cancer 1999, 81(6):918-922. 10.1002/(SICI)1097-0215(19990611)81:6<918::AID-IJC13>3.0.CO;2-E, 10362139.
7. Uchiyama A, Mukai M, Fujiwara Y, Kobayashi S, Kawai N, Murofushi H, Inoue M, Enoki S, Tanaka Y, Niki T, Kobayashi T, Tigyi G, Murakami-Murofushi K. Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta 2007, 1771(1):103-112.
8. Ishihara R, Tatsuta M, Iishi H, Baba M, Uedo N, Higashino K, Mukai M, Ishiguro S, Kobayashi S, Murakami-Murofushi K. Attenuation by cyclic phosphatidic acid of peritoneal metastasis of azoxymethane-induced intestinal cancers in Wistar rats. Int J Cancer 2004, 110(2):188-193. 10.1002/ijc.20069, 15069680.
9. Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 2008, 1781(9):513-518.
10. Baker DL, Fujiwara Y, Pigg KR, Tsukahara R, Kobayashi S, Murofushi H, Uchiyama A, Murakami-Murofushi K, Koh E, Bandle RW, Byun HS, Bittman R, Fan D, Murph M, Mills GB, Tigyi G. Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis. J Biol Chem 2006, 281(32):22786-22793. 10.1074/jbc.M512486200, 16782709.
11. Renback K, Inoue M, Ueda H. Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice. Neurosci Lett 1999, 270(1):59-61. 10.1016/S0304-3940(99)00464-4, 10454146.
12. Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 2004, 10(7):712-718. 10.1038/nm1060, 15195086.
13. Ueda H. Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Mol Pain 2008, 4:11. 10.1186/1744-8069-4-11, 2365930, 18377664.
14. Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain. J Pharmacol Exp Ther 2010, 333(2):540-546. 10.1124/jpet.109.164830, 20123931.
15. Inoue M, Ma L, Aoki J, Chun J, Ueda H. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain 2008, 4:6. 10.1186/1744-8069-4-6, 2277392, 18261210.
16. Matsumoto M, Inoue M, Hald A, Xie W, Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 2006, 318(2):735-740. 10.1124/jpet.106.103614, 16687474.
17. Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS, Chanda ML, Levitin DJ, Mogil JS. Social modulation of pain as evidence for empathy in mice. Science 2006, 312(5782):1967-1970. 10.1126/science.1128322, 16809545.
18. Kolesnikov Y, Cristea M, Oksman G, Torosjan A, Wilson R. Evaluation of the tail formalin test in mice as a new model to assess local analgesic effects. Brain Res 2004, 1029(2):217-223. 10.1016/j.brainres.2004.09.058, 15542077.
19. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 1998, 76(1-2):215-222. 10.1016/S0304-3959(98)00045-1, 9696476.
20. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980, 67(2-3):313-316. 10.1016/0014-2999(80)90515-4, 6893963.
21. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32(1):77-88. 10.1016/0304-3959(88)90026-7, 3340425.
22. Rashid MH, Inoue M, Kondo S, Kawashima T, Bakoshi S, Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 2003, 304(3):940-948.
23. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33(1):87-107. 10.1016/0304-3959(88)90209-6, 2837713.
24. Kissin I, Freitas CF, Bradley EL. Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats. Anesth Analg 2007, 104(5):1210-1216. 10.1213/01.ane.0000260296.01813.62, 17456676.
25. Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, Bramwell S, Corradini L, England S, Winks J, Kinloch RA, Hendrich J, Dolphin AC, Webb T, Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 2006, 103(46):17537-17542. 10.1073/pnas.0409066103, 1859964, 17088553.
26. Lengyel C, Torok T, Varkonyi T, Kempler P, Rudas L. Baroreflex sensitivity and heart-rate variability in insulin-dependent diabetics with polyneuropathy. Lancet 1998, 351(9113):1436-1437.
27. Katims JJ. Neuroselective current perception threshold quantitative sensory test. Muscle Nerve 1997, 20(11):1468-1469. 10.1002/(SICI)1097-4598(199711)20:11<1468::AID-MUS21>3.0.CO;2-X, 9342169.
28. Renback K, Inoue M, Yoshida A, Nyberg F, Ueda H. Vzg-1/lysophosphatidic acid-receptor involved in peripheral pain transmission. Brain Res Mol Brain Res 2000, 75(2):350-354.
29. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992, 77(4):757-763. 10.1097/00000542-199210000-00021, 1416174.
30. McCall WD, Tanner KD, Levine JD. Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 1996, 208(1):45-48. 10.1016/0304-3940(96)12552-0, 8731171.
31. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 2006, 109(1-2):57-77. 10.1016/j.pharmthera.2005.06.003, 16023729.
32. Hotta H, Kagitani F, Murakami-Murofushi K. Cyclic phosphatidic acid stimulates respiration without producing vasopressor or tachycardiac effects in rats. Eur J Pharmacol 2006, 543(1-3):27-31. 10.1016/j.ejphar.2006.05.017, 16806161.
33. Barnes CD, Eltherington LG. Chapter 2 "Anesthetic Doses". Drug dosage in laboratory animals: a handbook 1964, 15.
34. Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain 2009, 5(1):64. 10.1186/1744-8069-5-64, 2780384, 19912636.